Symposium in Vietnam to discuss integrated approach to defeating diarrheal disease

November 09, 2010

(Hanoi, Vietnam) - Each year, diarrheal disease claims the lives of 1.3 million children under five worldwide and hospitalizes millions more. The vast majority of these deaths occur in developing countries of Asia and Africa, but fortunately, interventions exist that can greatly reduce deaths and save lives. To bring attention to the solutions available today for defeating diarrhea, the Vietnam Ministry of Health, the National Pediatric Hospital of Vietnam, and PATH are hosting a two-day regional workshop where they will present the evidence and lessons learned from initiatives currently underway.

Vietnam's Ministry of Health recently unveiled new national "Guidelines for Management of Diarrheal Disease in Children," reinforcing the government's commitment to saving children's lives by preventing diarrhea-related illness. The guidelines add new interventions like zinc and low-osmolarity oral rehydration solution (ORS) to proven interventions including proper nutrition, hygiene, and continued breastfeeding, which have helped Vietnam reduce the number of diarrhea-related deaths among children under five during the past two decades.

"We hope that this conference empowers provincial health leaders to apply the new guidelines in their communities," said Dr. Luong Ngoc Khue, general director of the Vietnam Medical Health Services Administration. "We have the knowledge and tools to significantly reduce the health and economic burdens that diarrheal disease creates in Vietnam, and we want to encourage best practices across Asia."

The greatest burden of diarrheal disease in Vietnam falls on the rural poor, where access to clean water and simple, lifesaving treatments like ORS can be limited. The country had seen major gains through the provision of ORS, but in the past couple of years, officials noted that diarrheal morbidity and mortality had stagnated. The new clinical guidelines bring an opportunity to re-invigorate their commitment to this resilient--yet conquerable--killer.

The Mekong Regional Workshop on Diarrheal Disease Control will bring together policymakers and physicians from around the region to discuss strategies and next steps toward overcoming diarrheal disease. In addition to Vietnam's health leaders, officials from Cambodia and Laos also will discuss national strategies to prevent and treat childhood diarrhea. Other topics to be addressed include:"Stopping diarrheal disease illness and death is possible," said Dr. Le Thanh Hai, Vietnam National Hospital of Pediatrics, vice director and head of the emergency department. "Vietnam is making tremendous progress to control diarrhea-related child deaths and we hope that success in our country can encourage others in the region to increase uptake of simple, affordable, and effective solutions. This workshop is a wonderful opportunity to share what we are learning with the wider health community in Asia."

Rotavirus vaccines will be one major point of discussion at the event. Rotavirus is the leading cause of severe diarrheal disease in Vietnam and worldwide, but vaccines now exist that can greatly reduce its burden. In August, the Lancet published the first-ever clinical trial data on rotavirus vaccines in impoverished settings of Asia. Regionally representative results from Bangladesh and Vietnam showed the vaccines prevented nearly half of severe rotavirus disease. In Vietnam specifically, vaccines reduced severe rotavirus diarrhea by 72.3 percent during the first year of life, when children are at greatest risk. The Vietnamese National Institute of Hygiene and Epidemiology was a primary partner in the study, which contributed to the growing global evidence demonstrating the safety, efficacy, and lifesaving impact of rotavirus vaccines. They are not yet available in the public sector of Vietnam, but with the new data, demand in the region is growing.

"Rotavirus vaccines will be an important part of diarrhea control programs, as their availability increases," said Evan Simpson, program officer at PATH. "In the interim, we have been piloting efforts in Bihn Dinh province to implement the new clinical guidelines, and our collaboration with the Government of Vietnam and the National Pediatric Hospital is revealing the potential of a comprehensive set of interventions to prevent and combat severe diarrhea."

There is a growing consensus among medical and public health practitioners that effectively reducing the diarrheal disease burden will be a major step toward reaching the global Millennium Development Goals. But all available interventions must be accessible to those who need them. This requires a coordinated and integrated approach, supportive policies, and increased awareness among health care workers, communities, and caregivers.
-end-
PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH's work improves global health and well-being. To learn more, visit: www.PATH.org and www.DefeatDD.org

PATH

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.